Metraipolis › archive › dc_5ef450790741
Receptor antagonist — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Receptor_antagonist
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-15T14:47:50.151Z
- SHA-256 of the archived text
2b133b666848b231fe2d0434fb13c10b0ec2eb688dc79357a5ec9760ad1b456b- Stable URL of this page
https://metraipolis.com/documento/dc_5ef450790741
How to cite
Receptor antagonist — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Receptor_antagonist (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_5ef450790741 (Metraipolis archive dc_5ef450790741, sha256 2b133b666848b231fe2d0434fb13c10b0ec2eb688dc79357a5ec9760ad1b456b)
BibTeX
@misc{dc5ef450790741,
title = {Receptor antagonist — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Receptor_antagonist},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_5ef450790741; sha256 2b133b666848b231fe2d0434fb13c10b0ec2eb688dc79357a5ec9760ad1b456b},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Receptor_antagonist. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins. They are sometimes called blockers; examples include alpha blockers, beta blockers, and calcium channel blockers. In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors. Antagonists mediate their effects by binding to the active site or to the allosteric site on a receptor, or they may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity. Antagonist activity may be reversible or irreversible depending on the longevity of the antagonist–receptor complex, which, in turn, depends on the nature of antagonist–receptor binding. The majority of drug antagonists achieve their potency by competing with endogenous ligands or substrates at structurally defined binding sites on receptors. Tema degli esploratori: scienze della vita e salute (deposito sistematico; ricerca «pharmacology»). Fonte: Wikipedia in inglese, voce «Receptor antagonist» — https://en.wikipedia.org/wiki/Receptor_antagonist Wikidata Q410943 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q410943 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Receptor_antagonist?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1378339822, consultata il 2026-10-15T14:01:34.545Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: ea2f447f19bedb61ed50462432b047b721d08c898f7db1df16cd3fa3ecda5d86